Reuters Catches Up With FS On Medicating Toddlers
On Jan. 4, I let you all know about a study just out in the Journal of the American Academy of Child & Adolescent Psychiatry (and it’s still not online) concerning the doubling of antipsychotic use in toddlers aged 2 to 5. Well almost two weeks later the Reuters wire service reports on the study and notes that much of the uptick in toddlers is connected so-called child bipolar disorder.
“‘The psychiatric diagnosis of very young children is anything but an exact science,’ said Harry Tracy, a psychologist and publisher of NeuroInvestment, a monthly publication specializing in central nervous system disorders.
“‘Such disparate causes as ADHD, depression, bipolar disorder, sexual abuse, and family dysfunction can produce very similar symptoms in a toddler.’”
You don’t say. After banging on these sorts of issues in children for over three years, it’s nice to see Reuters casting a skeptical eye on this whole business. In their report, no one is actively defending these diagnoses and medications in toddlers. That tells you something.
Related posts:
Posted in Furious Seasons